FMP
NASDAQ
8.2 USD
-0.14 (-1.71%)
Mr. Ron Bentsur M.B.A.
Healthcare
Biotechnology
https://www.nuvectis.com
NASDAQ
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
0001875558
US67080T1088
67080T108
1 Bridge Plaza
201 614 3150
US
13
Feb 4, 2022